sparfloxacin has been researched along with Pneumococcal Infections in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (71.43) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nakabayashi, M; Niki, Y; Soejima, R; Tamada, S | 1 |
| Dupont, H; Gachot, B; Regnier, B; Souweine, B; Timsit, JF; Wolff, M | 1 |
| Jones, RN; Pfaller, MA | 1 |
| Bensch, G; Chodosh, S; DeAbate, CA; Harper, L; Henry, D; Jubran, A; Talbot, GH; Tipping, D | 1 |
| Hershberger, E; Rybak, MJ | 1 |
| Millichap, JJ; Noskin, GA; Pestova, E; Peterson, LR | 1 |
| Azoulay-Dupuis, E; Bergogne-Bérézin, E; Pocidalo, JJ; Vallée, E | 1 |
1 trial(s) available for sparfloxacin and Pneumococcal Infections
| Article | Year |
|---|---|
Sparfloxacin vs ofloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis: a multicenter, double-blind, randomized, comparative study. Sparfloxacin Multicenter ABECB Study Group.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bronchitis; Chlamydia Infections; Chlamydophila pneumoniae; Chronic Disease; Cough; Double-Blind Method; Enterobacter cloacae; Enterobacteriaceae Infections; Female; Fluoroquinolones; Haemophilus Infections; Haemophilus influenzae; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Moraxella catarrhalis; Neisseriaceae Infections; Ofloxacin; Placebos; Pneumococcal Infections; Quinolones; Sputum; Staphylococcal Infections; Treatment Outcome | 1998 |
6 other study(ies) available for sparfloxacin and Pneumococcal Infections
| Article | Year |
|---|---|
Sparfloxacin, a new generation fluoroquinolone against S. pneumoniae respiratory infections.
Topics: Animals; Anti-Infective Agents; Fluoroquinolones; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Pneumococcal Infections; Quinolones; Respiratory Tract Infections; Streptococcus pneumoniae; Survival | 1995 |
Torsades de pointe probably related to sparfloxacin.
Topics: Anti-Infective Agents; Female; Fluoroquinolones; Humans; Mastoiditis; Middle Aged; Otitis Media; Pneumococcal Infections; Quinolones; Torsades de Pointes | 1996 |
Comparative antistreptococcal activity of two newer fluoroquinolones, levofloxacin and sparfloxacin.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; Humans; In Vitro Techniques; Levofloxacin; Ofloxacin; Pneumococcal Infections; Quinolones; Streptococcal Infections; Streptococcus; Streptococcus pneumoniae | 1997 |
Activities of trovafloxacin, gatifloxacin, clinafloxacin, sparfloxacin, levofloxacin, and ciprofloxacin against penicillin-resistant Streptococcus pneumoniae in an in vitro infection model.
Topics: Anti-Infective Agents; Blood Coagulation; Ciprofloxacin; Fibrin; Fluoroquinolones; Gatifloxacin; Humans; Levofloxacin; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Penicillin Resistance; Pneumococcal Infections; Streptococcus pneumoniae | 2000 |
Intracellular targets of moxifloxacin: a comparison with other fluoroquinolones.
Topics: Anti-Infective Agents; Aza Compounds; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; Drug Resistance, Microbial; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Moxifloxacin; Mutation; Pneumococcal Infections; Polymerase Chain Reaction; Quinolines; Reserpine; Sequence Analysis, DNA; Streptococcus pneumoniae | 2000 |
Pharmacokinetics of four fluoroquinolones in an animal model of infected lung.
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Disease Models, Animal; Fluoroquinolones; Lung Diseases; Mice; Mice, Inbred Strains; Ofloxacin; Pneumococcal Infections; Quinolones; Streptococcus pneumoniae | 1991 |